Antibody delivery mediated by recombinant adeno-associated virus
(Bentham Science Publishers) Monoclonal antibody (mAb) based-therapies have revolutionized treatments of cancer and autoimmune diseases because of their specificity and limited toxicity
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news
More News: Adenoviruses | Autoimmune Disease | Cancer | Cancer & Oncology | Infectious Diseases | Science | Toxicology